12 septembre 2018 |

Evenements

American Academy of Ophthalmology, Chicago (IL)

GS010 – Leber’s Hereditary Optic Neuropathy (LHON) 

Oral presentation:  Efficacy of rAAV2/2-ND4, an Investigational Gene Therapy for ND4 LHON: Top-line Results of Phase 3 Clinical Trial REVERSE

• Presenting Author:  Mark L. Moster, MD, Neuro-Ophthalmology, Wills Eye Hospital and Professor of Neurology and Ophthalmology at Thomas Jefferson University, Philadelphia, PA (Investigator in REVERSE and RESCUE trials)
• Session Date/Time: Monday, October 29, 2018, 2:12 PM – 2:19 PM
• Topic Title: Retina, Vitreous
• Room: S405
• Final abstract number: PA066